Medical Microbiology and Immunology

Papers
(The H4-Index of Medical Microbiology and Immunology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests98
The human symbiont Mucispirillum schaedleri: causality in health and disease81
Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting66
Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing57
Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern46
Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test41
Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis40
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings37
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants26
Potential biomarkers of immune protection in human leishmaniasis22
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity22
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality20
Interferon antagonists encoded by SARS-CoV-2 at a glance19
Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis18
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission18
0.033791065216064